BSEBoard Meeting26 Oct 2026 · 26 Oct 2026, 01:17 pm

Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September, 2026 and to consider any other matter with the permission of the Chairman.

Anuh Pharma Ltd · 506260

✦ AI SummaryResults

Anuh Pharma Ltd has scheduled a Board Meeting on 30th October, 2026 to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Anuh Pharma Ltd - 506260 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2026.

Attachments (1)

📄

0e78143a-d11f-4f2e-a01a-1b8eab4edf14.pdf

pdf

Download →
View document text
Date: 26th October, 2026 To, To, The Manager (Listing) Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Fort, Mumbai - 400 001. Bandra-Kurla Complex, BSE Symbol: ANUHPHR Bandra (E), Mumbai – 400051. BSE Scrip Code: 506260 NSE Symbol: ANUHPHR; Series: EQ Sub: Intimation of Board Meeting scheduled to be held on 30th August, 2026 Dear Sir/Madam, Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 30th October, 2026, at the registered office of the Company, inter-alia, to consider and approve the following agenda items; 1) To consider, approve and take on record the Un-Audited Financial Results for the quarter and half year ended 30th September, 2026; 2) To transact any other business with the permission of the chair. Further, pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Company's Code of Conduct for prevention of Insider Trading, the Trading window for dealing in the securities of the Company has been closed for the Designated Persons and their immediate relatives, from Thursday, 01st October, 2026 and shall remain closed until 48 hours after the declaration of Audited Financial Results till Sunday, 01st November, 2026 (both days inclusive). You are requested to take the above information on record and disseminate the same on your website. Thanking you, Yours faithfully, FOR ANUH PHARMA LIMITED MANAN VADHAN COMPANY SECRETARY & COMPLIANCE OFFICER Place: Mumbai